We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michel Azizi

Michel Azizi MD, PhD

Professor of Vascular Medicine, Université Paris-Descartes, Paris, France & AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department, Paris, France
Michel Azizi (born april 4, 1958) is Professor of Vascular Medicine at Paris Descartes University and Head of the Hypertension Unit and of the Clinical Investigation Center, Georges Pompidou University Hospital, Paris. He received his MD from René Descartes University and his PhD from Pierre et Marie Curie University, Paris, France. He is past member of the Clinical Research Commission of the INSERM, in France. He is past Vice-President of the European Society of Hypertension.
Dr. Azizi's main research interests include the medication-based and device-based treatment of resistant hypertension, adherence to treatment and the physiology, genetics and pharmacology of the renin–angiotensin–aldosterone system. He has published more than 200 papers in peer reviewed journals, many of which have focused on the renin-angiotensin-system and resistant hypertension. He has received the Jean Hamburger prize for Medical Research in 2007, the University Paris-Descartes Scientific Award in 2009, 2013, and 2017, Paris, France, the Peter van Zwieten award of the European Society of Hypertension in 2011, Milan, Italy, the Scientific award of the Italian Society of Hypertension in 2013, the Scientific award of the Portuguese Society of Hypertension in 2016, the Paul Milliez award at the European Society of Hypertension in 2017, The 2019 Research prize of the magazine “La Recherche” Paris, France,. He is member of the French Society of Hypertension, French Society of Cardiology, the European Society of Hypertension, and the European Society of Cardiology.

Disclosures

Dr. Azizi reports the following disclosures:

Institutional Research Grant: ReCor Medical, Servier, Novartis, Quantum Genomics, Idorsia, The French Ministry of Health, The French Federation of Cardiology; Honoraria: Actelion, Idorsia, Novartis, CVRx, Servier, and Astra.